NewAmsterdam Pharma Company N.V.
NASDAQNewAmsterdam Pharma heads into the autumn with a curious split: short interest has risen sharply over the past month while the options market has turned markedly less bearish — two signals pointing in opposite directions on a stock already down 8% in a month. The short side tells a clear story of accumulating pressure. Short interest has climbed 38% in a month, reaching 11.2% of…
NAMS short interest surges 20.2% in one week to 8.1% of float, driven by biotech volatility and pipeline catalysts.
Snapshot as of 5 Sept 2026
NewAmsterdam Pharma heads into the autumn with a curious split: short interest has risen sharply over the past month while the options market has turned markedly less bearish — two signals pointing in opposite…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NAMS — free to start on ORTEX.
Sign up for free →Open NAMS on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live NAMS data →